Introduction
T he countries of Europe, with their many similarities but also their great differences, have long been a platform for natural experiments in public health, with the geo-political divide in population health being explored extensively in many studies. [1] [2] [3] However, even today, despite continuing improvements almost everywhere, large gaps among countries remain.
Wider determinants of health, such as environment and climate, diets and behaviours, as well as political, social and economic circumstances have all played a major role in the epidemiological transition and health trajectories over the past century. 1, 2 But so did health systems, 4 as well as policies acting on the social determinants of health. 3 The particular combination of these factors has allowed some countries to achieve much better health outcomes than others, offering researchers scope to understand the reasons for successes and failures of health policies across Europe.
Previous research has examined some remarkable policy experiments in Europe in the past three decades. These include the reunification of Germany, leading to rapid improvements in health in the East of the country 5 ; the disastrous effects of the rapid political, economic and social changes that followed the collapse of the Soviet Union 6, 7 ; and differences in paths to recovery by seemingly similar countries in the Baltic States 8 and Central Europe. 9 However, even in Western Europe, which enjoyed political stability and financial prosperity for most of that time, variations in health outcomes are considerable (e.g. life expectancy in Denmark is 2 years below that in Sweden), and can largely be attributed to actions (or failures to act) of policy makers. 10, 11 It should, however, be noted that, while analysing Europe as a distinct region, defining it presents many challenges, as its geographical, political and historical boundaries are inconsistent. In this paper, for reasons of simplicity and data availability, we include countries of the European Union, divided into pre-and post-2004 members (Western and Southern Europe and Central Europe, respectively), as well as countries of the Former Soviet Union (Eastern Europe and Central Asia), to broadly represent Europe by these three regions. We then examine trends and changes in life expectancy at birth, broadly comparing these three regions over the past 25 years.
Methods
We used WHO detailed mortality files (updated in April 2017) 12 to obtain mortality and population figures of the countries included, from 1990 to 2015 (or latest, see Supplementary Appendix S1 for data availability). Data were grouped by age (under 1, 1-4, 5-9, . . ., 80-84, 85+) and sex. We constructed life tables for the years 1990, 1995, 2000, 2005, 2010 and 2015 and decomposed changes in life expectancy using the method developed by Arriaga. 13 This technique makes it possible to measure the contribution of specific age groups to changes in life expectancy over the years. We analysed these contributions to change in life expectancy in the regions over 25 years compared with the starting point in 1990. We defined three broad regions: (i) Western and Southern Europe, consisting of the 15 countries which were members of the EU before 2004; (ii) Central Europe (plus Malta and Cyprus), consisting of the 13 countries which have joined the EU in or after 2004 and (iii) Eastern Europe and Central Asia, consisting of the 12 countries which initially formed the Commonwealth of Independent States (CIS) after the fall of the Soviet Union. We used the WHO Health for All Database (released July 2016) 14 to analyse changes in life expectancy in 1990-2015 in specific countries.
Results
Europe remains divided geographically by population longevity, with countries with the longest life expectancy in the West and countries with the lowest life expectancy in the East. Over the past 25 years the increase has been steady in the West, compared to mixed progress in other regions. By 2015, few of the countries in the East, all of which had scope to improve considerably, were on a trajectory that would allow them to converge with Western Europe. Over the course of 25 years the mortality situation has changed markedly in all countries in Europe. Figure 2 shows patterns of change in life expectancy by age group, for men and women in the three regions. 
Eastern Europe and Central Asia
Over the course of 25 years, life expectancy at birth in Eastern Europe and Central Asia increased by only 1.3 years for males and 2.1 years for females, with a slow recovery from the initial drop in life expectancy between 1990 and 1995, when life expectancy fell by 4.5 years for males and 2.4 years for females. The initial decline in life expectancy in 1995 was driven by increases in mortality in both genders and most age groups, but was particularly pronounced in males of working age. This pattern remained stable between 1995 and 2005, and any gains in life expectancy over that time were largely driven by reducing infant mortality. Meaningful improvement was only seen in 2010 and it was only after that when life expectancy in the region started to exceed that in 1990. Strikingly, even in 2015 survival of young men and women (aged 25-44) is still below that of 1990, contributing negatively to recent gains in overall life expectancy. In terms of older ages, little has changed in the pattern of mortality in men over 75, but improvements in older women account for almost half of the total gains. 
Central Europe

Western and South Europe
Between 1990 and 2015 life expectancy at birth in Western and South Europe increased by 6.3 years for males and 4.6 years for females, with each of the 5-year periods marked by at substantial improvement. In males, the improvements were greatest among those aged 55 and above, although peaking at around 80, while among females, improvements increased progressively in older age groups. Patterns over time were similar but improvements among women over 85 only began to accelerate after 2005.
Convergence or divergence?
Gender and regional gaps persist. In Eastern Europe and Central Asia, the already wide gender gap in life expectancy has increased even further between 1990 and 2015, from 9.7 to 10.4 years, respectively. In the rest of the region it has decreased, but to a smaller extent in Central Europe (from 8.1 to 7.3 years) and larger extent in the West (from 6.7 years to 5.0 years). The gap between regions is even more striking. It nearly doubled from 8.7 in 1990 to 16.0 years in 2005 between Eastern and Western males, and remains at 13.6 years in 2015. Among females, the pattern was similar but less pronounced. Central Europe also lags substantially behind the West, with the gap in 1990 being 6.1 years for men and 4.7 years for women, while by 2015 it was still 6 years for males, but had narrowed to 3.7 years for females.
Discussion
Our analysis highlights the continuation of a vast and prolonged divide in population health across Europe. We show that, while in Western Europe life expectancy has increased markedly, particularly due to a reduction in mortality in older ages, Eastern Europe has only seen modest improvements, accounted for by reductions in infant and premature mortality, particularly in men, and, only recently, by some modest progress in older age women. Strikingly, even in 2015, mortality of young adults, males and females, in Eastern Europe exceeds the levels of 1990.
Before we discuss the broad drivers of these changes, there are some important limitations to highlight. First, the analysis is based on the available mortality data, which is subject to problems of accuracy and availability. This is particularly relevant for countries of the South Caucasus and Central Asia (Armenia, Azerbaijan, Georgia, Tajikistan, Turkmenistan and Uzbekistan). Second, we 
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have not performed decomposition in individual countries, due to the broad scope of this paper. However, later in the discussion we summarize the findings of recent studies of regions where countrylevel analyses have been undertaken. Third, regional averages are weighted towards countries with larger populations, and therefore, higher number of deaths. On one hand, this provides a more accurate representation of the regions' populations as a whole but it also diminishes the visibility of trends in smaller countries. Finally, by looking at the regional picture, we have not captured inequalities within countries, such as the limited progress in improving health of the Roma population. 15 However, the issue of inequalities is addressed in detail in another paper in this supplement.
Broadly, over the past 25 years Europe has followed the path of health transition, 16 characterized by a reduction of cardio-vascular mortality in the West, with convergence among countries, and divergence of trajectories in the East, which have now begun to narrow. The key point, that there is a persisting divide between the East and the West, should not come as a major surprise. What is new and important, however, is the pattern of change over time within the regional populations. While in Western Europe changes in life expectancy were largely due to very substantial gains in older ages, survival of older people, particularly men, in the East has barely changed. This means that positive gains in Eastern Europe and Central Asia largely represent the reinstatement of the pattern of health in 1990, rather than any progress made since then.
The change in mortality patterns over that time has been studied extensively. In Eastern Europe and Central Asia, initial falls in life expectancy occurred due to unprecedented rise in deaths from external causes (including in countries without civil conflict) and cardio-vascular mortality, which, for instance, represented over 80% of the total increase in Belarus and Russia between 1990 and 1994. 17 These changes were accompanied by a more general deterioration of socio-economic conditions, under-financing and under-development of health systems, as well as deregulation and poor control of health hazards such as tobacco, alcohol, illicit drugs. 18 For example, a study examining differences in mortality between Russia, the Baltic States and the UK shows that Russia experienced deeper and more prolonged deterioration in mortality than the Baltics in 1990 s. 19 Figure 2 Decomposition of change in life expectancy 1990-2015 by region, sex and age group. Note: Decomposition of change in life expectancy for regions by sex is shown in years of change for each age group between base year (1990) and selected years (1995, 2000, 2005, 2010 and 2015) 6
14 More recently, however, there was an improvement, suggesting that they were finally tackling its high burden of cardiovascular disease, with improvement in many areas, including improved diet, reduced alcohol consumption, expansion of modern effective treatment, and a general improvement of economic conditions. 20, 21 In Belarus the initial mortality decline was less steep, and the recovery was more gradual, in comparison to Russia, as it opted for a more gradual socio-economic transition. 17 Both countries have benefitted from strengthened alcohol control in recent years, but these measures alone do not account for all improvement, and recent favorable trends need to be viewed more broadly. 22 Other Eastern European countries (Ukraine and Moldova) show a pattern broadly similar to Belarus. Countries of the South Caucasus, as well as Central Asian countries, have gaps in data completeness and accuracy, with research suggesting that official life expectancy figures are being overestimated. 18, 23 However, a study comparing mortality in Kyrgyzstan to that of Russia in 1980-2010 24 showed, again, that the Russian mortality crisis was an extreme case, while other former Soviet Union Republics experienced broadly similar, but less steep trajectories (except the effect of civil conflict in Tajikistan). However, there is also some evidence that, in these republics, Russian minorities may have been most affected. 25 As we see from the analysis, the recent improvements are yet to have a meaningful positive effect on the older people, particularly men. While some key steps have been made recently in tackling tobacco and alcohol consumption, particularly in Russia, health systems in these countries are yet to overcome major inefficiencies, fragmentation, weak primary care and outdated treatment practices. 18 In Central Europe, changes in life expectancy are more positive throughout the period, although little gain was seen initially. In part this is due to the inclusion of the Baltic States, where life expectancy trajectories in early 1990 s are similar to other countries of the former Soviet Union. Even within these three states there are important differences, with Estonia's life expectancy improving much more rapidly in comparison to Lithuania, which experienced another, albeit smaller, drop in mid 2000 s, driven by increases in cardio-vascular, road-traffic and alcohol-related deaths. 8 Variations are also seen between other former socialist countries. Bulgaria, the Czech Republic, Hungary, Poland, Slovakia, and Romania are united by showing a substantial decrease in cardio-vascular deaths over 1990 s and 2000 s but divided by differences in the onset of improvement and the scale of reductions in alcohol-related and road-traffic deaths, as well as cancers (including lung and breast cancer), suggesting that impact of specific intersectoral policies in each country have played an important role. 9 Our analysis shows that gains in life expectancy were due to substantial improvements in infant mortality, particularly earlier on, as well as improvements in mortality across most age groups in males, roughly equally distributed between 45 and 80 year olds, and peaking in females over 60.
In Western and Southern Europe, which is generally characterized by much higher life expectancy than Central or Eastern parts of the region, the picture across countries is much more uniform. But even there, there are notable exceptions, such as Denmark with the lowest life expectancy for women-the legacy of very high smoking rates. 26 However, much of the region seems to have now entered a new stage of health transition, characterized by slower ageing. 16 With cardiovascular mortality substantially reduced across the region, other causes of death now contribute to improvements in life expectancy, particularly treatable and preventable cancers, as well as Alzheimer's Disease and dementia, which now are among the leading causes of death in Western Europe. 27 The latter phenomenon is also reflected in our analysis, which shows that greatest gains since 1990 were made in older ages, while contributions of changes due to reductions in infant mortality were much smaller than in other regions. Notably, the progress in the past few years was quite modest compared to earlier periods, which suggests that the scope for further improvement in life expectancy at older (75+) ages and beyond is diminishing. Indeed, the UK has even seen an increase in mortality in this age group over the recent years, associated with the impact of cuts to pensioners income and social care. 28, 29 Almost three decades after the political transition in Europe, many countries have yet to achieve their full potential to improve health and, worryingly, their current trajectory suggests that they are still making far too little progress. Yet, there are also many examples of success that, if adopted more widely, could bring about real improvements. This requires both availability of resources, but also a willingness among policy makers to act. This paper marks the 25th anniversary of the European Public Health Association (EUPHA). EUPHA has provided a forum for exchanging knowledge on health in Europe, contributing to some of the successes reported in this paper. We hope that the analyses presented here will stimulate further discussion and, ultimately, better health for all Europeans.
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